Pietri, E., Andreis, D., Fabbri, F., Menna, C., Schirone, A., Kopf, B., . . . De Giorgi, U. (2015). A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. Oncologist.
Chicago Style citaatPietri, Elisabetta, Daniele Andreis, Francesca Fabbri, Cecilia Menna, Alessio Schirone, Barbara Kopf, Andrea Rocca, Dino Amadori, en Ugo De Giorgi. "A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide On Days 1 and 4 Every 14 Days With Filgrastim Support Followed By Weekly Paclitaxel in Women With Primary Breast Cancer." Oncologist 2015.
MLA citatiePietri, Elisabetta, et al. "A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide On Days 1 and 4 Every 14 Days With Filgrastim Support Followed By Weekly Paclitaxel in Women With Primary Breast Cancer." Oncologist 2015.